Reviva Pharmaceuticals
Manufacturing · California, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
10080 N Wolfe Rd Ste SW3200, Cupertino, ...Phone Number
(408) 501-8881Website
www.revivapharma.comRevenue
$41.7 MillionStock Symbol
RVPHIndustry
About Reviva Pharmaceuticals
Reviva Pharmaceuticals Inc is a clinical-stage pharmaceutical company. It is focused on discovering and developing novel therapies for central nervous system, respiratory, and metabolic diseases. Its lead drug candidate, brilaroxazine (RP5063), is in clinical development for multiple unmet neuropsychiatric indications including schizophrenia, bipolar disorder, major depressive disorder, behavioral and psychotic symptoms in Alzheimers disease, Parkinsons disease psychosis, and attention deficit hyperactivity disorder (ADHD). The company is headquartered in Cupertino, California.Explore more
Reviva Pharmaceuticals Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to Reviva Pharmaceuticals
Compare insights from companies similar to Reviva Pharmaceuticals, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Reviva Pharmaceuticals Tech Stack
A closer look at the technologies used by Reviva Pharmaceuticals
Top Manufacturing Companies
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Reviva Pharmaceuticals
Sign Up For FreeTo access detailed company insights
Reviva Pharmaceuticals Inc is a clinical-stage pharmaceutical company. It is focused on discovering and developing novel therapies for central nervous system, respiratory, and metabolic diseases. Its lead drug candidate, brilaroxazine (RP5063), is in clinical development for multiple unmet neuropsychiatric indications including schizophrenia, bipol... Read More
